Ascensia Diabetes Care US INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$724Kgeneral payments (2019-2025)
$515Kresearch payments (2019-2025)
4,271clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Gary Graf | Topeka, KS | Nurse Practitioner | $48,657.61 |
| Mark Corriere | Columbia, MD | Internal Medicine | $43,970.16 |
| David Ahn | Newport Beach, CA | Endocrinology, Diabetes & Metabolism | $36,902.72 |
| Amir Harari | Scottsdale, AZ | Endocrinology, Diabetes & Metabolism | $19,538.39 |
| Kelsey Furr | West Jordan, UT | Nurse Practitioner | $18,882.32 |
| Natasha Gibbs | Austin, TX | Nurse Practitioner | $11,866.25 |
| Bantwal Baliga | Opelika, AL | Endocrinology, Diabetes & Metabolism | $11,131.06 |
| Bruce Bode | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $9,146.04 |
| Steven Edelman | San Diego, CA | Internal Medicine | $8,935.43 |
| Anthony Pick | Lake Forest, IL | Endocrinology, Diabetes & Metabolism | $8,397.99 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.